Back to search
BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a single arm phase 1b/2 evaluation of the combination of oregovomab, and bevacizumab, paclitaxel carboplatin in adult subjects with CA125-associated, ad…
The aim of the study is to explore a prognostic clinical and molecular biomarker profile in a population of BRCA wild-type recurrent high-grade ovarian cancer p…
This study is phase II, open label, clinical trial to determine the efficacy of Olaparib maintenance with Bevacizumab and Pembrolizumab by assessment progressio…